Neuroepidemiology

Neuroepidemiology is a branch of epidemiology involving the study of neurological disease distribution and determinants of frequency in human populations. The term was first introduced by Dr. Len Kurland, Dr. Milton Alter and Dr. John F. Kurtzke in 1967. Traditionally, neuroepidemiology has been perceived for a long time as a science of incidence, prevalence, risk factors, natural history and prognosis of neurological disorders. However, this is only one part of neuroepidemiology, called non-experimental neuroepidemiology. The other integral, but commonly forgotten, part of neuroepidemiology is experimental neuroepidemiology, which is research based on clinical trials of effectiveness or efficacy of various interventions in neurological disorders. Neuroepidemiology is a branch of epidemiology involving the study of neurological disease distribution and determinants of frequency in human populations. The term was first introduced by Dr. Len Kurland, Dr. Milton Alter and Dr. John F. Kurtzke in 1967. Traditionally, neuroepidemiology has been perceived for a long time as a science of incidence, prevalence, risk factors, natural history and prognosis of neurological disorders. However, this is only one part of neuroepidemiology, called non-experimental neuroepidemiology. The other integral, but commonly forgotten, part of neuroepidemiology is experimental neuroepidemiology, which is research based on clinical trials of effectiveness or efficacy of various interventions in neurological disorders. In 1982, Karger set up a new journal entitled ''. This periodical is the only international journal devoted to the study of neurological disease distribution and determinants of frequency in human populations. Since the time of its inception in 1982, the scope of 'Neuroepidemiology' journal has evolved considerably. At present, the journal publishes manuscripts on all aspects of epidemiology of neurological disorders, including clinical trials and systematic reviews. Its primary focus is on chronic and acute neurological disorders of major importance to clinical medicine, public health, and health care delivery. The journal also welcomes manuscripts dealing with methodological issues in neuroepidemiological studies. In 2017, Dr. George Jelinek, Head of the Neuroepidemiology Unit at The University of Melbourne, and founder of Overcoming Multiple Sclerosis, LTD, an Australian not-for-profit organization was posted as Specialty Chief Editor of Frontiers in Neurology section.